Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00252
|
|||||
| Drug Name |
Bilirubin
|
|||||
| Synonyms |
21H-Biline-8,12-dipropanoic acid, 2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-; AI3-23078; BPYKTIZUTYGOLE-IFADSCNNSA-N; BRN 0074376; Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-; Bilirubin IX-alpha; Bilirubin IXalpha; Bilirubin, 99%; CHEBI:16990; EINECS 211-239-7; Hematoidin; Hemetoidin; MFCD00005499; NSC 26685; PHEOPHYTIN; Principal bile pigment; RFM9X3LJ49; UNII-RFM9X3LJ49
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C33H36N4O6
|
|||||
| Canonical SMILES |
CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)C=C3C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)C=C4C(=C(C(=O)N4)C=C)C
|
|||||
| InChI |
InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-
|
|||||
| InChIKey |
BPYKTIZUTYGOLE-IFADSCNNSA-N
|
|||||
| CAS Number |
CAS 635-65-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 584.7 | Topological Polar Surface Area | 164 | ||
| Heavy Atom Count | 43 | Rotatable Bond Count | 12 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
2.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10319019
, 103619919
, 111677770
, 113853139
, 11537670
, 117636345
, 124636399
, 126522981
, 126628628
, 127269546
, 127269547
, 127269548
, 127269549
, 134977906
, 135252701
, 135253133
, 137144061
, 138836811
, 144072300
, 14935827
, 24848604
, 24891751
, 25630735
, 26612105
, 26681048
, 26749657
, 3769
, 39289522
, 47348442
, 47868681
, 47942824
, 49746883
, 49834296
, 49893925
, 50096481
, 50096483
, 53789017
, 57357704
, 57647150
, 80330271
, 8144728
, 85245571
, 85248032
, 85248034
, 8616233
, 87563495
, 88266590
, 92718032
, 99455424
, 99455426
|
|||||
| ChEBI ID |
CHEBI:16990
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [1] | |
| OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [2] | ||
| OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [2] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | MRP2 | Transporter Info | Km = 0.7 microM | Human embryonic kidney cells (HEK293)-MRP2 | [1] | |
| MRP2 | Transporter Info | Km = 0.9 microM | Human embryonic kidney cells (HEK293)-MRP2 | [1] | ||
| OATP1B1 | Transporter Info | Km = 0.1 microM | Human embryonic kidney cells (HEK293)-OATP1B1 | [3] | ||
| OATP1B1 | Transporter Info | Km = 0.28 microM | Human embryonic kidney cells (HEK293)-OATP1B1 | [3] | ||
| OATP1B1 | Transporter Info | Km = 0.0076 microM | Oocytes-OATP1B1 | [2] | ||
| OATP1B3 | Transporter Info | Km = 0.5 microM | Human embryonic kidney cells (HEK293)-OATP1B3 | [3] | ||
| OATP1B3 | Transporter Info | Km = 0.0391 microM | Oocytes-OATP1B3 | [2] | ||
| References | ||||||
| 1 | Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology. 1999 Aug;30(2):485-90. | |||||
| 2 | Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem J. 2003 May 1;371(Pt 3):897-905. | |||||
| 3 | Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.